Oct 22, 2026 08:00AM
Jun 24, 2026 08:32AM
Jun 24, 2026 08:30AM
Apr 20, 2026 08:04AM
Apr 20, 2026 08:00AM
Mar 10, 2026 08:00AM
Mar 10, 2026 08:00AM LENZ Therapeutics Announces Submission of Marketing Authorization Application to European Medicines Agency for VIZZ® for the Treatment of Presbyopia
Jan 14, 2026 08:30AM
Jan 7, 2026 05:08PM
Jan 5, 2026 08:04AM
Jan 5, 2026 08:00AM
Dec 12, 2025 04:28PM
Dec 1, 2025 08:30AM
Oct 27, 2025 06:52AM H.C. Wainwright Reiterates Buy Rating on LENZ Therapeutics Inc (LENZ)
Sep 30, 2025 08:06AM
Sep 30, 2025 08:05AM
Aug 22, 2025 06:52AM
Aug 4, 2025 06:37AM
Aug 1, 2025 11:11AM
Jul 31, 2025 05:25PM
Jul 7, 2025 08:02AM LENZ Therapeutics (LENZ) licenses LNZ100 eye drop to Théa for Canada market
Jul 7, 2025 08:00AM
Jun 10, 2025 05:05AM
May 9, 2025 09:04AM
May 9, 2025 09:03AM
May 6, 2025 04:30PM
Apr 1, 2025 07:00AM
Mar 20, 2025 06:40AM H.C. Wainwright Reiterates Buy Rating on LENZ Therapeutics Inc (LENZ)
Oct 27, 2024 09:00PM
Aug 15, 2024 08:44AM
Aug 15, 2024 04:58AM
Apr 3, 2024 07:00AM
Apr 3, 2024 07:00AM
Mar 21, 2024 04:32PM
Mar 21, 2024 04:30PM LENZ Therapeutics Announces Completion of Merger with Graphite Bio and Provides Update on Recent Clinical and Corporate Progress

335,223 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All